S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
CVE:PVT

Pivotree (PVT) Stock Forecast, Price & News

C$2.80
0.00 (0.00%)
(As of 05:18 PM ET)
Compare
Today's Range
C$2.80
▼
C$2.82
50-Day Range
C$2.66
▼
C$3.60
52-Week Range
C$2.66
▼
C$4.00
Volume
468 shs
Average Volume
14,818 shs
Market Capitalization
C$74.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$6.00
ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlines

Pivotree MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
114.3% Upside
C$6.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.75mentions of Pivotree in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.61 out of 5 stars

See Top Rated MarketRank™ Stocks Here

PVT stock logo

About Pivotree (CVE:PVT) Stock

Pivotree Inc. designs, integrates, deploys, and manages digital platforms in commerce, data management, and supply chain for retail and branded manufacturers in Canada and internationally. It operates in two segments, Professional Services and Managed Services. The company offers a combination of application support and managed hosting with digital strategy and software implementation services. It provides its services to B2B, B2C, distribution, finance, healthcare, hospitality, insurance, manufacturing, retail, technology, and telecommunication industries. The company was formerly known as Reliant Web Hosting Inc. and changed its name to Pivotree Inc. in September 2020. Pivotree Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Receive PVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pivotree and its competitors with MarketBeat's FREE daily newsletter.

PVT Stock News Headlines

May 31, 2023 | americanbankingnews.com
Cormark Comments on Pivotree Inc.'s FY2023 Earnings (CVE:PVT)
May 20, 2023 | americanbankingnews.com
Pivotree (CVE:PVT) PT Lowered to C$7.00 at National Bankshares
May 31, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 17, 2023 | americanbankingnews.com
FY2024 EPS Estimates for Pivotree Inc. (CVE:PVT) Boosted by Analyst
April 25, 2023 | americanbankingnews.com
Pivotree Inc. (CVE:PVT) Expected to Earn Q1 2023 Earnings of ($0.01) Per Share
April 5, 2023 | americanbankingnews.com
National Bank Financial Comments on Pivotree Inc.'s FY2023 Earnings (CVE:PVT)
April 4, 2023 | americanbankingnews.com
Pivotree Inc. to Post FY2023 Earnings of ($0.06) Per Share, Cormark Forecasts (CVE:PVT)
April 2, 2023 | americanbankingnews.com
National Bank Financial Weighs in on Pivotree Inc.'s FY2024 Earnings (CVE:PVT)
May 31, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
April 2, 2023 | americanbankingnews.com
Pivotree (CVE:PVT) PT Raised to C$5.50 at Canaccord Genuity Group
March 31, 2023 | americanbankingnews.com
Pivotree Inc. (CVE:PVT) Expected to Post FY2024 Earnings of $0.17 Per Share
March 31, 2023 | americanbankingnews.com
Pivotree (CVE:PVT) Price Target Cut to C$5.50 by Analysts at Cormark
April 28, 2022 | benzinga.com
Pivotree Selected to Lead Digital Transformation and MDM Strategy for World's Largest Hybrid Packaging Supplier
See More Headlines
Receive PVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pivotree and its competitors with MarketBeat's FREE daily newsletter.

PVT Company Calendar

Last Earnings
3/29/2023
Today
5/31/2023
Next Earnings (Estimated)
8/24/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Information Technology Services
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
CVE:PVT
CUSIP
N/A
CIK
N/A
Web
pivotree.com
Phone
877 767 5577
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$6.00
High Stock Price Forecast
C$7.00
Low Stock Price Forecast
C$5.50
Forecasted Upside/Downside
+114.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
C($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-7,200,000.00
Net Margins
-7.04%
Pretax Margin
N/A
Return on Equity
-11.23%
Return on Assets
-5.15%

Debt

Debt-to-Equity Ratio
2.20
Current Ratio
2.33
Quick Ratio
1.95

Sales & Book Value

Annual Sales
C$102.24 million
Price / Sales
0.73
Cash Flow
C$0.47 per share
Price / Cash Flow
5.98
Book Value
C$2.41 per share
Price / Book
1.16

Miscellaneous

Outstanding Shares
26,650,000
Free Float
N/A
Market Cap
C$74.62 million
Optionable
Not Optionable
Beta
0.63

Key Executives

  • Mr. William Di Nardo
    CEO & Director
  • Mr. Moataz Ashoor
    CFO, Admin. Officer & Corp. Sec.
  • Mr. Ted Smith Jr.
    Chief Operations Officer
  • Mr. Todd Jurkuta
    Pres
  • Mr. Chris MacLean
    VP of Technology
  • Mr. Raj Atwal
    Sr. VP of Corp. Devel.
  • Ms. Sarah Kirk Douglas
    VP of Marketing
  • Ms. Ira Kapoor
    VP of Talent Management
  • Mr. Edgar Aranha
    Chief People & Culture Officer
  • Mr. James Urbati
    Sr. VP of Product Management

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













PVT Stock - Frequently Asked Questions

Should I buy or sell Pivotree stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pivotree in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" PVT shares.
View PVT analyst ratings or view top-rated stocks.

What is Pivotree's stock price forecast for 2023?

1 equities research analysts have issued 12 month target prices for Pivotree's shares. Their PVT share price forecasts range from C$5.50 to C$7.00. On average, they expect the company's stock price to reach C$6.00 in the next year. This suggests a possible upside of 114.3% from the stock's current price.
View analysts price targets for PVT or view top-rated stocks among Wall Street analysts.

How have PVT shares performed in 2023?

Pivotree's stock was trading at C$3.32 on January 1st, 2023. Since then, PVT shares have decreased by 15.7% and is now trading at C$2.80.
View the best growth stocks for 2023 here.

When is Pivotree's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 24th 2023.
View our PVT earnings forecast.

How were Pivotree's earnings last quarter?

Pivotree Inc. (CVE:PVT) announced its earnings results on Wednesday, March, 29th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.06. The company had revenue of $26.16 million for the quarter, compared to analyst estimates of $24.25 million. Pivotree had a negative trailing twelve-month return on equity of 11.23% and a negative net margin of 7.04%.

What is Pivotree's stock symbol?

Pivotree trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PVT."

How do I buy shares of Pivotree?

Shares of PVT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Pivotree's stock price today?

One share of PVT stock can currently be purchased for approximately C$2.80.

How much money does Pivotree make?

Pivotree (CVE:PVT) has a market capitalization of C$74.62 million and generates C$102.24 million in revenue each year. The company earns C$-7,200,000.00 in net income (profit) each year or C($0.25) on an earnings per share basis.

How can I contact Pivotree?

The official website for the company is pivotree.com. The company can be reached via phone at 877 767 5577.

This page (CVE:PVT) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -